Data month 2026-08
According to AlphaMoat, in 2026-08 DrugCard (drug-card.io) received 7,239 monthly visits (-27% MoM) — ranked #10,969 of 17,401 AI websites with traffic data, and #1,717 of 3,146 in Industry Services; its largest market is United States (45.7% of visits).
Monthly Visits · 2026-08
7.2K-27%
Overall Rank (17,401)
#10,969
Industry Services Rank (3,146)
#1,717
Top Market
United States45.7%
What is DrugCard
Product Overview
DrugCard is an AI pharmacovigilance tool providing automated literature screening and regulatory intelligence for drug-safety teams, streamlining daily pharmacovigilance workflows.
Key Features6 items
- 01Automated literature monitoring
- 02pharmacovigilance screening
- 03regulatory intelligence
- 04simplify drug-safety workflows
- 05global and local regulatory coverage
- 06assist audit compliance
12-Month Traffic Trend
Hover for monthly values
Latest 7.2KMoM-27%YoY+18.2%
2025-09
6.5K
+6.6%
2025-10
7.1K
+8.9%
2025-11
5.4K
-24.4%
2025-12
5.3K
-0.5%
2026-01
4.1K
-22.6%
2026-02
5.5K
+31.9%
2026-03
5.2K
-5.5%
2026-04
3.7K
-28.4%
2026-05
5.6K
+51.1%
2026-06
9.4K
+68.1%
2026-07
9.9K
+5.6%
2026-08
7.2K
-27.0%
Visits by Country · Top 5
2026-08 · Share of total visits
United States
3,30745.7%
India
1,46720.3%
UK
92712.8%
Canada
90112.4%
Poland
5127.1%
Popular in Industry Services
Click for details, or "+ Compare" to compare with DrugCard
Data month: 2026-08 · Visit figures are third-party traffic estimates aggregated monthly — best for scale and trends. Multiple domains of the same product are merged. See methodology.